MTMT-ben szereplő publikációk tallózása szerző szerint "Scharf JM"

A találatok rendezése: Rendezés: Találatok:

  • Rare Copy Number Variants in NRXN1 and CNTN6 Increase Risk for Tourette Syndrome 
    Huang AY; Yu D; Davis LK; Sul JH; Tsetsos F; Ramensky V; Zelaya I; Ramos EM; Osiecki L; Chen JA; McGrath LM; Illmann C; Sandor P; Barr CL; Grados M; Singer HS; Nothen MM; Hebebrand J; King RA; Dion Y; Rouleau G; Budman CL; Depienne C; Worbe Y; Hartmann A; Muller-Vahl KR; Stuhrmann M; Aschauer H; Stamenkovic M; Schloegelhofer M; Konstantinidis A; Lyon GJ; McMahon WM; Barta, Csaba; Tárnok, Zsanett; Nagy, Péter; Batterson JR; Rizzo R; Cath DC; Wolanczyk T; Berlin C; Malaty IA; Okun MS; Woods DW; Rees E; Pato CN; Pato MT; Knowles JA; Posthuma D; Pauls DL; Cox NJ; Neale BM; Freimer NB; Paschou P; Mathews CA; Scharf JM; Coppola G; Tourette Syndrome Association International Consortium for Genetics (TSAICG); Gilles de la Tourette Syndrome GWAS Replication Initiative (GGRI) (2017)
    Tourette syndrome (TS) is a model neuropsychiatric disorder thought to arise from abnormal development and/or maintenance of cortico-striato-thalamo-cortical circuits. TS is highly heritable, but its underlying genetic ...
  • TS-EUROTRAIN: A European-wide investigation and training network on the etiology and pathophysiology of Gilles de la Tourette Syndrome 
    Forde NJ; Kanaan AS; Widomska J; Padmanabhuni SS; Nespoli E; Alexander J; Rodriguez Arranz JI; Fan S; Houssari R; Nawaz MS; Rizzo F; Pagliaroli, Luca; Zilhäo NR; Arányi, Tamás; Barta, Csaba; Boeckers TM; Boomsma DI; Buisman WR; Buitelaar JK; Cath D; Dietrich A; Driessen N; Drineas P; Dunlap M; Gerasch S; Glennon J; Hengerer B; Van den Heuvel OA; Jespersgaard C; Möller HE; Müller-Vahl KR; Openneer TJC; Poelmans G; Pouwels PJW; Scharf JM; Stefansson H; Tümer Z; Veltman DJ; Van der Werf YD; Hoekstra PJ; Ludolph A; Paschou P (2016)
    Gilles de la Tourette Syndrome (GTS) is characterized by the presence of multiple motor and phonic tics with a fluctuating course of intensity, frequency, and severity. Up to 90% of patients with GTS present with comorbid ...